XML 39 R12.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statements of Shareholder's Equity - SB/RH - USD ($)
$ in Millions
Total
Total Shareholders' Equity
Accumulated Earnings (Deficit)
Accumulated Other Comprehensive Loss
Non- controlling Interest
SB/RH
SB/RH
Total Shareholders' Equity
SB/RH
Other Capital
SB/RH
Accumulated Earnings (Deficit)
SB/RH
Accumulated Other Comprehensive Loss
SB/RH
Non- controlling Interest
Balance at beginning of period at Sep. 30, 2020 $ 1,415.8 $ 1,407.5 $ 243.9 $ (284.7) $ 8.3 $ 1,265.2 $ 1,255.3 $ 2,154.1 $ (614.2) $ (284.6) $ 9.9
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net (loss) income from continuing operations 15.3 15.1 15.1   0.2 17.3 17.1   17.1   0.2
Income (loss) from discontinued operations, net of tax 174.3 174.5 174.5   (0.2) 174.3 174.5   174.5   (0.2)
Other comprehensive income (loss), net of tax 49.8 49.4   49.4 0.4 49.8 49.4     49.4 0.4
Restricted stock issued and related tax withholdings (4.9) (4.9) 0.0     (7.3) (7.3) (7.3)      
Share based compensation 29.7 29.7       28.0 28.0 28.0      
Dividend paid to common shareholders (73.6) (73.6) (73.6)     (192.3) (192.3)   (192.3)    
Dividend paid by subsidiary to NCI (1.6)       (1.6) (1.6)         (1.6)
Balance at end of period at Sep. 30, 2021 1,479.0 1,471.9 359.9 (235.3) 7.1 1,333.4 1,324.7 2,174.8 (614.9) (235.2) 8.7
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net (loss) income from continuing operations (77.0) (77.2) (77.2)   0.2 (75.0) (75.2)   (75.2)   0.2
Income (loss) from discontinued operations, net of tax 149.7 148.8 148.8   0.9 149.7 148.8   148.8   0.9
Other comprehensive income (loss), net of tax (68.7) (67.8)   (67.8) (0.9) (68.7) (67.8)     (67.8) (0.9)
Restricted stock issued and related tax withholdings (24.5) (24.5)       (24.5) (24.5) (24.5)      
Share based compensation 15.4 15.4       14.3 14.3 14.3      
Dividend paid to common shareholders (69.4) (69.4) (69.4)     (194.7) (194.7)   (194.7)    
Dividend paid by subsidiary to NCI (1.4)       (1.4) (1.4)         (1.4)
Balance at end of period at Sep. 30, 2022 1,269.1 1,263.2 362.1 (303.1) 5.9 1,133.1 1,125.6 2,164.6 (736.0) (303.0) 7.5
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net (loss) income from continuing operations (233.7) (233.8) (233.8)   0.1 (226.3) (226.4)   (226.4)   0.1
Income (loss) from discontinued operations, net of tax 2,035.6 2,035.3 2,035.3   0.3 2,035.6 2,035.3   2,035.3   0.3
Sale and deconsolidation of assets held for sale 19.4 25.3   25.3 (5.9) 19.4 25.3     25.3 (5.9)
Other comprehensive income (loss), net of tax 28.7 28.4   28.4 0.3 28.7 28.4     28.4 0.3
Restricted stock issued and related tax withholdings (12.9) (12.9)       (12.9) (12.9) (12.9)      
Share based compensation 18.6 18.6       17.2 17.2 17.2      
Dividend paid to common shareholders (67.6) (67.6) (67.6)     (305.1) (305.1)   (305.1)    
Balance at end of period at Sep. 30, 2023 $ 2,518.3 $ 2,517.6 $ 2,096.0 $ (249.4) $ 0.7 $ 2,689.7 $ 2,687.4 $ 2,168.9 $ 767.8 $ (249.3) $ 2.3